Literature DB >> 20309881

Loss of MKK4 expression in ovarian cancer: a potential role for the epithelial to mesenchymal transition.

Shamima Yeasmin1, Kentaro Nakayama, Mohammed Tanjimur Rahman, Munmun Rahman, Masako Ishikawa, Atsuko Katagiri, Kouji Iida, Naomi Nakayama, Kohji Miyazaki.   

Abstract

In the current study, we investigated the mechanism relating downregulation of mitogen-activated protein kinase kinase 4 (MKK4) expression to development of ovarian cancer. Over-expression of the MKK4 gene in TOV-21 G cells, a line with homozygous deletion of MKK4, resulted in morphologic changes in which cells growing in a scattered, fibroblast-like pattern formed tightly packed colonies. Based on a wound healing assay and a Matrigel invasion assay, we determined that both motility and invasiveness of MKK4-transfected TOV-21G cells were significantly reduced compared to control vector-transfected cells. To confirm that MKK4 expression related to tumor invasion resulted from an epithelial to mesenchymal transition (EMT)-like morphological change, we used 2 independent but complementary approaches. MKK4 gene knockdown in MDAH 2774 cells over-expressing MKK4 increased invasion activity. Additionally, engineered expression of MKK4 in SKOV3 cells, a line with low endogenous MKK4 expression, produced a phenotype similar to that of TOVG-21G. Interestingly, we found that MKK4 upregulation caused downregulation of phosphorylated NF-κB and Twist, as well as upregulation of E-cadherin, in TOVG-21G and SKOV3 cells. Reciprocal results were obtained in MDAH 2774 cells with MKK4 knockdown. Our results suggest that MKK4 downregulation causes increased phosphorylation NF-κB. This promotes Twist over-expression, resulting in E-cadherin downregulation that induces EMT in ovarian cancer.
Copyright © 2010 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20309881     DOI: 10.1002/ijc.25332

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis.

Authors:  Trang T Pham; Steven P Angus; Gary L Johnson
Journal:  Genes Cancer       Date:  2013-11

2.  Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.

Authors:  Russell O Bainer; Jennifer Taylor Veneris; S Diane Yamada; Anthony Montag; Mark W Lingen; Yoav Gilad; Carrie W Rinker-Schaeffer
Journal:  Clin Exp Metastasis       Date:  2012-02-21       Impact factor: 5.150

3.  Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor γ2 expression.

Authors:  Young-Ho Ahn; Yanan Yang; Don L Gibbons; Chad J Creighton; Fei Yang; Ignacio I Wistuba; Wei Lin; Nishan Thilaganathan; Cristina A Alvarez; Jonathon Roybal; Elizabeth J Goldsmith; Cathy Tournier; Jonathan M Kurie
Journal:  Mol Cell Biol       Date:  2011-09-06       Impact factor: 4.272

Review 4.  Twist: a molecular target in cancer therapeutics.

Authors:  Md Asaduzzaman Khan; Han-chun Chen; Dianzheng Zhang; Junjiang Fu
Journal:  Tumour Biol       Date:  2013-07-20

Review 5.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

6.  Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.

Authors:  Sally J Davis; David Y H Choong; Manasa Ramakrishna; Georgina L Ryland; Ian G Campbell; Kylie L Gorringe
Journal:  BMC Cancer       Date:  2011-05-17       Impact factor: 4.430

7.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

8.  Registered report: Diverse somatic mutation patterns and pathway alterations in human cancers.

Authors:  Vidhu Sharma; Lisa Young; Anne B Allison; Kate Owen
Journal:  Elife       Date:  2016-02-19       Impact factor: 8.140

9.  Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis.

Authors:  Anna A Marusiak; Natalie L Stephenson; Hayeon Baik; Eleanor W Trotter; Yaoyong Li; Karen Blyth; Susan Mason; Phil Chapman; Lorena A Puto; Jon A Read; Claire Brassington; Hannah K Pollard; Chris Phillips; Isabelle Green; Ross Overman; Matthew Collier; Ewelina Testoni; Crispin J Miller; Tony Hunter; Owen J Sansom; John Brognard
Journal:  Cancer Res       Date:  2015-12-04       Impact factor: 12.701

Review 10.  Mechanisms of ovarian cancer metastasis: biochemical pathways.

Authors:  Kentaro Nakayama; Naomi Nakayama; Hiroshi Katagiri; Kohji Miyazaki
Journal:  Int J Mol Sci       Date:  2012-09-18       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.